Wanda Filer, MD, MBA, FAAFP, discusses the prevalence of RSV.
Considerations for the Management of Respiratory Syncytial Virus (RSV)
Wanda Filer, MD, MBA, FAAFP, provides an overview of the potential outcomes for patients of all ages with RSV.
Dr Filer highlights the considerations for the rollout of new RSV vaccines.
Financial burden associated with RSV treatment is explored by a medical expert.
In her closing thoughts, Dr Filer provides insights into the unmet needs in the treatment of RSV.
Advertisement
Advertisement
Trending on AJMC
1
Cumulative Atropine Not Associated With Increased Risk of Ocular Events in Children With Myopia
2
West Coast Health Alliance Releases First Vaccine Guidelines, Aiming to Replace CDC Recommendations
3
Hospitals in Underserved Communities Less Likely to Adopt Health Information Technology
4
Sotatercept Shows Right Heart Gains in PAH: Anjali Vaidya, MD
5
